[HTML][HTML] In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692
O Dömötör, M Mathuber, CR Kowol - European Journal of Pharmaceutical …, 2024 - Elsevier
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and an investigational inhibitor KP2692.
O Dömötör, M Mathuber, CR Kowol - European Journal of …, 2023 - europepmc.org
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692
O Dömötör, M Mathuber… - European journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
[引用][C] In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692
O Dömötör, M Mathuber… - EUROPEAN …, 2024 - publicatio.bibl.u-szeged.hu
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692
O Dömötör, M Mathuber, CR Kowol - EUROPEAN JOURNAL OF …, 2024 - real.mtak.hu
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …